FlandersBio

Contact
flandersbio.be
+3292418041

FlandersBio

Rijvisschestraat 118 b1
9052 Gent
Belgium
+3292418041
flandersbio.be
Contact
Profile News
Contact

About FlandersBio

FlandersBio is the umbrella organisation for the Life Sciences sector in Flanders, a dynamic non-profit, fee based organisation with 210 members. Its mission is to support and facilitate the sector’s sustained development.

Read more about FlandersBio
Facts about FlandersBio
  • Industry : Biotechnology

News about FlandersBio

FlandersBio

18-Jan-2013 | people

Biocartis strengthens management team with general counsel

Biocartis announced that Inge Basteleurs has joined the company as General Counsel. Inge will be a member of Biocartis’ Executive Committee and a director ...

Read news
FlandersBio

13-Jun-2012 | business & finance

Multiplicom receives €200,000 grant for novel non-invasive pre-natal test

IWT grant to support development of early aneuploidy detection during pregnancy

Read news
FlandersBio

13-Oct-2011 | science

Karyopharm Therapeutics Inc. and Katholieke Universiteit Leuven Sign Exclusive Collaboration for the Discovery of Novel CRM1/Exportin 1 Inhibitors

Karyopharm Therapeutics Inc. has initiated an exclusive collaboration in the area of Selective Inhibitors of Nuclear Export (SINE) modulators of the CRM1 ...

Read news
FlandersBio

22-Mar-2011 | research and development

FORMAC obtains EMA Orphan Drug Designation for FP110

FORMAC Pharmaceuticals N.V. announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to FORMAC's FP110.This Orphan Drug ...

Read news
FlandersBio

22-Sep-2010 | business & finance

European Investment Fund and K.U.Leuven invest 16 million euro in Centre for Drug Design and Discovery

The Katholieke Universiteit Leuven and the European Investment Fund (EIF) are investing an additional 16 million euro in the Centre for Drug Design and ...

Read news
FlandersBio

16-Sep-2010 | science

Katholieke Universiteit Leuven enters into license agreement with Pfizer for the development of new anti-HIV drugs

Katholieke Universiteit Leuven (K.U.Leuven, Belgium) announced that on July 29th, 2010 they entered into a license agreement with Pfizer. The license ...

Read news
FlandersBio

10-Sep-2010 | business & finance

Roche and reMYND enter into a strategic alliance to develop treatments for Parkinson’s and Alzheimer’s disease

Roche and reMYND announced that they have entered into an agreement to develop novel therapeutics that could slow down neurodegeneration in Parkinson’s ...

Read news
FlandersBio

30-Jun-2010 | research and development

PharmaNeuroBoost’s lead product in major depression receives IND approval from FDA

PharmaNeuroBoost NV (PNB) reported that the U.S. Food and Drug Administration (FDA) approved the Investigational New Drug (IND) application for PNB01. ...

Read news
Show more news about FlandersBio

Here you will find FlandersBio